SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-026591
Filing Date
2022-11-09
Accepted
2022-11-09 16:06:03
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20220930_10q.htm   iXBRL 10-Q 722567
2 EXHIBIT 31.1 ex_439470.htm EX-31.1 11473
3 EXHIBIT 31.2 ex_439471.htm EX-31.2 11458
4 EXHIBIT 32.1 ex_439472.htm EX-32.1 4601
5 EXHIBIT 32.2 ex_439473.htm EX-32.2 4504
  Complete submission text file 0001437749-22-026591.txt   3881978

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcda-20220930.xsd EX-101.SCH 45272
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20220930_def.xml EX-101.DEF 271525
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20220930_lab.xml EX-101.LAB 243257
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20220930_pre.xml EX-101.PRE 300953
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20220930_cal.xml EX-101.CAL 30248
55 EXTRACTED XBRL INSTANCE DOCUMENT bcda20220930_10q_htm.xml XML 528117
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 221372526
SIC: 2836 Biological Products, (No Diagnostic Substances)